RDD Asia 2014

Published: 10-Jul-2014

12 - 14 November 2014

Scientific conference

Goa, India


This is the first Respiratory Drug Delivery (RDD) conference in Asia that will bring pulmonary and nasal drug delivery experts from all over the world to Goa, India.

Expert speakers will address a blend of contemporary issues and essential background relating to pMDIs, DPIs, nebulisers, nasal sprays and emerging aerosol delivery platforms.

Organisers: Aptar Pharma and RDD Online

www.rddonline.com/rddasia2014

Trending Articles

  1. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  2. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  3. Interphex 16-18 April 2024 | Conference and Exhibition | New York, US
  4. Vision Pharma <b>28 February - 1 March 2012</b><br> <i>Exhibition</i><br> Messe Karlsruhe, Germany
  5. Advanced Characterisation Techniques for Solid Pharmaceutical Dosage Forms <b>5 July 2013</b><br> <i>PSSRC Open Day</i><br> University of Lille, France

You may also like

Drug Delivery

Aptar Digital Health and Gerresheimer collaborate to develop integrated solution for subcutaneous cancer therapy

Collaboration aims to deliver an innovative solution to improve overall patient treatment adherence and clinical outcomes
Research & Development

Aptar Digital Health and Legit.Health partner to improve patient experience in immuno-dermatology

Collaboration will integrate Legit.Health's innovative technology into Aptar Digital Health’s proprietary digital health platform to better manage and treat skin conditions
Packaging

Pharmapack 2023 "pivotal moment for sustainability in drug delivery and packaging"

Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Manufacturing

Aptar launches metal-free nasal spray pump

APF Futurity nasal spray pump certified Highly Recyclable by cyclos-HTP
Manufacturing

Aptar Pharma collaborates with TFF Pharmaceuticals on dry powder vaccines

TFF Pharmaceutical’s Thin Film Freezing technology platform has broad applicability to convert drugs (small and large molecules) and vaccines into a dry powder formulation for local administration
Drug Delivery

Aptar starts $180m expansion to leverage injection system solutions

An additional factory in Granville, France will be operational as of early 2024, which leverages the latest technology
Drug Delivery

Aptar partner with Fluidda on nasal drugs

The companies will leverage their respective proprietary technology platforms to help accelerate U.S. Food & Drug Administration (FDA) approvals
Subscribe now